Description
Description
Doxorubicin is a cytotoxic anthracycline antibiotic isolated from cultures of Streptomyces peucetius var. caesius. Doxorubicin binds to nucleic acids, presumably by specific intercalation of the planar anthracycline nucleus with the DNA double helix.
Drug type: Doxorubicin (liposomal) is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. It is the drug doxorubicin encapsulated in a closed lipid sphere (liposome). This medication is classified as an “anthracycline antibiotic.”
Indications
- Acute Lymphoblastic Leukaemias (ALL)
- Acute Myeloblastic Leukemia
- Advanced Endometrial Cancer
- Advanced Soft Tissue Sarcoma
- Bladder transitional cell carcinoma
- Carcinoma, Bronchogenic
- Gastric Carcinoma
- Kaposi’s Sarcoma AIDS Related
- Lymphoma, Hodgkins
- Malignant Lymphomas
- Metastatic Breast Cancer
- Multiple Myeloma (MM)
- Neuroblastomas
- Ovarian Cancer Metastatic
- Ovarian Carcinoma
- Sarcoma, Bone
- Soft Tissue Sarcoma (STS)
- Thyroid Carcinoma
- Advanced uterine sarcoma
Strength:
| Generic Name | Strength | Standard | Type | Packing | Pack Size |
| Liposomal Doxorubicin | 20 / 50mg | USP/IP | Vial | Vial | Per vial |

0
Reviews
There are no reviews yet.